SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

SanDisk is caught in a broader memory-stock selloff, with traders focused on concerns that Chinas CXMT could add competition and pressure sector pricing, alongside wider worries about AI valuations and macro conditions. The community is split between expecting further declines and viewing the China threat as overstated, arguing that SanDisks NAND business differs from CXMTs DRAM focus and that AI-related storage demand remains supportive.

Taiwan Semiconductor Manufacturing Co., Ltd. engages in the manufacture and sale of integrated circuits and wafer semiconductor devices. Its chips are used in personal computers and peripheral products, information applications, wired and wireless communications systems products, and automotive and industrial equipment including consumer electronics such as smartphones, digital television, game consoles, and digital cameras. The company was founded by Chung Mou Chang on February 21, 1987 and is headquartered in Hsinchu, Taiwan.

Taiwan Semiconductor Manufacturing - ADR

TSMCs quarterly report is the focus, with traders highlighting strong revenue and profit growth tied to AI-chip demand. The shares decline despite the strong results has fueled debate over a sell-the-news reaction, lofty expectations, and broader weakness in semiconductor and AI stocks.

SK hynix, Inc. engages in the design, manufacture, and sale of semiconductor products. Its products include dynamic random access memory, not-AND flash memory, and multi-chip package. The company was founded on October 15, 1949 and is headquartered in Icheon, South Korea.

SK Hynix Inc - ADR

SK Hynix is under pressure amid a sharp South Korean semiconductor selloff, with traders citing fears of rising Chinese memory-chip competition, doubts about AI spending and broader macro concerns. Bulls argue the CXMT threat is overstated and view the pullback as a buying opportunity, while bears warn that competition and memory-cycle risks could prolong the decline.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

Hot inflation data and a sharp semiconductor and AI-stock selloff are weighing on the S&P 500, as traders worry about higher Fed rates and watch turmoil in Korean markets. The community is split between dip-buying and expecting a deeper correction, with producer-price data seen as a key test.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is under pressure after pushing Neutrons first flight to 2027 because of carbon-composite tank manufacturing issues. Traders are split between viewing the delay as prudent quality control and seeing it as another execution setback that postpones growth; some consider the selloff an overreaction, while broader weakness in space stocks is also mentioned.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

The FDA expanded Anktivas approval to include BCG-unresponsive papillary-only bladder cancer, broadening the eligible patient population and drawing intense attention to IBRX. Many traders see the decision as a major commercial and regulatory positive, while others are disappointed by the muted share-price reaction and question whether the news was already priced in; claims of short-driven suppression remain speculation.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

Hotter-than-expected inflation revived Fed rate-hike worries as a semiconductor and AI-linked tech selloff, alongside weakness in South Korean chip stocks, pressured QQQ. Traders are split between fears of a deeper AI-led correction and views that the pullback could offer a buying opportunity or relief bounce.

Direxion Shares ETF Trust - Direxion Daily MSCI South Korea Bull 3X ETF

Direxion Daily South Korea Bull 3X Shares

KORU is under pressure as South Korean stocksespecially Samsung and SK Hynixsell off amid concerns about Chinese memory-chip competition, AI-sector weakness, and foreign investor outflows; its 3x leverage magnifies the moves. Traders are divided between buying the steep decline and warning that further losses and forced liquidations could follow.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeaves selloff is centered on Gartners warning that many neocloud providers may not remain independent, alongside concern that the companys high debt burden and sharply elevated bond yields could make expansion financing harder; hot inflation and rate-hike fears added pressure. Traders are split between viewing the drop as an overreaction given AI demand and potential Nvidia support, and seeing debt and refinancing risks as a threat to the business.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidia is caught in a broad semiconductor and AI-stock selloff as hotter-than-expected inflation raises rate-hike concerns and weakness in South Korean chip stocks fuels worries about competition and memory supply. Traders are also divided over whether debt-heavy AI infrastructure spending is sustainable, with bears warning of an AI bubble and bulls viewing the pullback as a buying opportunity.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Zacks Industry Outlook Highlights ICU Medical, Neogen and Trulieve Cannabis

ICU Medical, Neogen and Trulieve Cannabis offer distinct growth catalysts as medical products demand benefits from innovation, resilient procedures and evolving market opportunities.

3 Medical Product Stocks Positioned to Ride on the Industry Tailwinds

Here, we highlight three medical product stocks, ICUI, NEOG and TRLV, which are well positioned to benefit from industry tailwinds and could be worth adding to investors' portfolios.

ICU Medical CFO Sells 6,381 Shares for $1.1 Million

Key PointsThe sale involved shares equal to 10% of the CFO's direct equity stake held prior to the transaction...

ICU Medical CFO Brian Bonnell Sells 9,307 Shares

Key PointsThe transaction involved shares equal to 13% of the stake held before the filing...

BAX Raises 2026 Outlook as Strong Q2 Growth Offsets Margin Pressure

Baxter raises its 2026 sales and earnings outlook after strong Q2 growth, though manufacturing costs, tariffs and pricing pressure margins.

Ben Sousa Executes Sell Order: Offloads $401K In ICU Medical Stock

A substantial insider sell was reported on August 12, by Ben Sousa, Chief Information Officer at ICU Medical (NASDAQ:ICUI), based on the recent SEC filing.
What Happened: After conducting a thorough analysis, Sousa soldread more...

ICU Medical Analysts Boost Their Forecasts Following Upbeat Q2 Earnings

ICU Medical Inc (NASDAQ:ICUI) reported strong Q2 earnings of $2.37 per share and raised its FY2026 guidance. Analysts have increased price targets for the stock.read more...

ICU Medical (ICUI) Reports Q2 Earnings: What Key Metrics Have to Say

While the top- and bottom-line numbers for ICU Medical (ICUI) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

ICU Medical (ICUI) Tops Q2 Earnings and Revenue Estimates

ICU Medical (ICUI) delivered earnings and revenue surprises of +24.08% and +2.33%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Bio-Rad Laboratories (BIO) Beats Q2 Earnings Estimates

Bio-Rad (BIO) delivered earnings and revenue surprises of +11.97% and -0.97%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

ICU Medical, Inc. engages in the provision of innovative medical products used in infusion therapy and critical care applications. Its product portfolio includes IV smart pumps, sets, connectors, closed system transfer devices for hazardous drugs, sterile IV solutions, cardiac monitoring systems, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. The company was founded by George A. Lopez in 1984 and is headquartered in San Clemente, CA.

ICU Medical, Inc.

Neutral Sentiment

Hotter than expected

As expected

Cooler than expected

The September Producer Price Index report lands Thursday, October 15 at 8:30 AM ET, one day after CPI, with August’s reading at 5.4% year over year, as investors look for clues on inflation before the Fed’s October 27-28 meeting. How will the September PPI print compare to consensus expectations? Vote and explain your reasoning in the comments.

How will the September PPI print compare to consensus expectations?

Feed

News

Sentiment

Earnings

Fundamentals

Info

ICUI News